Paul G. Montgomery, MD - Hematology/Oncology

Provided by: Healthwise
Not yet rated

Dr. Paul G. Montgomery reviews medical content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. Dr. Montgomery is a medical oncologist with the Mountain States Tumor Institute at St. Luke's Regional Medical Center in Boise, Idaho. He is a Clinical Instructor for the University of Washington in Seattle.

Board Certifications

American Board of Internal Medicine—1988
Subspecialty Certification in Hematology (ABIM)—1990
Subspecialty Certification in Oncology (ABIM)—1991

Healthwise Knowledgebase Topics Reviewed

Prostate Cancer

Education

M.D.: University of Washington Medical School, Seattle, 1985
Internal Medicine Residency: Mayo Clinic, Rochester, MN, 1985–1988
Hematology Fellowship: Mayo Clinic, Rochester, MN, 1988–1990
Oncology Fellowship: Mayo Clinic, Rochester, MN, 1990–1991

Academic Appointments

Clinical Instructor in Medicine, University of Washington, Seattle, 1993–present

Hospital Affiliations

Idaho Elks Rehabilitation Hospital, Boise, ID
Saint Alphonsus Regional Medical Center, Boise, ID
St. Luke's Regional Medical Center, Boise, ID
Veterans Administration Medical Center, Boise, ID
St. Luke's Magic Valley Regional Medical Center, Twin Falls, ID

Professional Affiliations

Fellow, American College of Physicians
American Society of Clinical Oncology
American Society of Hematology

Selected Publications

  1. Kamel OW, van de Rijn M, Weiss LM, et al. (1993). Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. New England Journal of Medicine, 328(18): 1317–1321.
  2. Weaver CH, Bensinger WI, Applebaum FR, et al. (1994). Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies. Bone Marrow Transplantation, 14(5): 813–819.
  3. Bensinger QI, Schiffman KS, Holmberg L, et al. (1997). High-dose busulfan, melphalan, thiotepa, and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplantation, 19(12): 1183–1189.
  4. Bensinger W, Applebaum F, Rowley S, et al. (1995). Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology, 13(10): 2547–2555.

Financial Disclosure

This reviewer reported no financial conflicts.

© 1995-2007, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701. ALL RIGHTS RESERVED.

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information. For more information, click here. Privacy Policy. How this information was developed.

Was this article helpful?
Tell us what you think.

Be the first to rate!
liked it no thanks

In the Spotlight

Anemia Facts and Myths

Have you ever been told you were anemic? Were you advised to take iron? Did it make you feel better?

More fact and fiction »

Yahoo! Groups

Join the Conversation:

Join a Yahoo! Group and discuss topics with other members of the group.

All Blood Disorders Groups »

Tell us what you think about Yahoo! Health - Send us your feedback